What does Apotheek Mertens do?

Apotheek Mertens is a pharmacy in Genk. Private Limited, started on 14 May 1985, 1 establishment.

What is the address of Apotheek Mertens?

The registered office of Apotheek Mertens is located at Zaveldriesstraat 14, 3600 Genk.

Is Apotheek Mertens still active?

Yes. According to the CBE (30 October 2026) Apotheek Mertens is active, legal situation “Normale toestand”, started on 14 May 1985.

Is Apotheek Mertens registered on Peppol?

Yes, Apotheek Mertens is registered on the Peppol network with ID 0208:0427269459.

What is the enterprise number of Apotheek Mertens?

The enterprise number of Apotheek Mertens is BE0427269459.

When was Apotheek Mertens founded?

Apotheek Mertens was founded on 14 May 1985.

Who are the directors of Apotheek Mertens?

According to the 2025 annual accounts, the directors of Apotheek Mertens are: DESPO BV.

Is Apotheek Mertens a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 May 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Mertens make in 2025?

Apotheek Mertens posted a profit after taxes of € 250,307 in financial year 2025.

What is the revenue of Apotheek Mertens?

As a small company, Apotheek Mertens is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 491,157.

How much does an employee at Apotheek Mertens earn?

The average wage cost per full-time employee at Apotheek Mertens was € 84,600 in 2025: staff costs of € 177,578 for 2.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Mertens have?

According to the 2025 annual accounts, Apotheek Mertens has 2.1 full-time equivalents (FTE).

Apotheek Mertens (Private Limited) - Genk - BE0427269459

Dossier Apotheek Mertens, printed on 30 October 2026 from databakkes.be/en/0427269459/apotheek-mertens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Mertens from Genk, company number BE0427269459, closed financial year 2025 with a result of € 250,307 after tax. For that financial year Apotheek Mertens recorded a gross margin of € 491,157 and equity of € 112,000. Compared with financial year 2024, the result moved from € 270,145 to € 250,307. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What it is worth Healthy

€ 112,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 250,307

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 161,131

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 250,307 paid out

100 % of the profit went to the shareholders, mostly to DESPO (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.1

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 177,578

▲ 25% vs 2024

€ 84,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 452

▼ 61% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 223,560

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,518

▲ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 411,303 Gross margin 2022: € 411,303 First fiscal year in the series	€ 422,278 Gross margin 2023: € 422,278 ▲ 3% vs 2022 (€ 411,303) Favourable step	€ 469,815 Gross margin 2024: € 469,815 ▲ 11% vs 2023 (€ 422,278) Favourable step	€ 491,157 Gross margin 2025: € 491,157 ▲ 5% vs 2024 (€ 469,815) Favourable step	▲ 5%
Profit after taxes	€ 237,771 Profit after taxes 2022: € 237,771 First fiscal year in the series	€ 238,729 Profit after taxes 2023: € 238,729 Unchanged (€ 237,771) Favourable step	€ 270,145 Profit after taxes 2024: € 270,145 ▲ 13% vs 2023 (€ 238,729) Favourable step	€ 250,307 Profit after taxes 2025: € 250,307 ▼ 7% vs 2024 (€ 270,145) Unfavourable step	▼ 7%
Equity	€ 111,126 Equity 2022: € 111,126 First fiscal year in the series	€ 111,855 Equity 2023: € 111,855 ▲ 1% vs 2022 (€ 111,126) Favourable step	€ 112,000 Equity 2024: € 112,000 Unchanged (€ 111,855) Favourable step	€ 112,000 Equity 2025: € 112,000 Unchanged (€ 112,000) Unchanged
Total debts	€ 745,166 Total debts 2022: € 745,166 First fiscal year in the series	€ 861,984 Total debts 2023: € 861,984 ▲ 16% vs 2022 (€ 745,166) Unfavourable step	€ 1,074,694 Total debts 2024: € 1,074,694 ▲ 25% vs 2023 (€ 861,984) Unfavourable step	€ 1,286,895 Total debts 2025: € 1,286,895 ▲ 20% vs 2024 (€ 1,074,694) Unfavourable step	▲ 20%
Cash	€ 303,121 Cash 2022: € 303,121 First fiscal year in the series	€ 146,911 Cash 2023: € 146,911 ▼ 52% vs 2022 (€ 303,121) Unfavourable step	€ 187,924 Cash 2024: € 187,924 ▲ 28% vs 2023 (€ 146,911) Favourable step	€ 161,131 Cash 2025: € 161,131 ▼ 14% vs 2024 (€ 187,924) Unfavourable step	▼ 14%
Land & buildings	€ 5,279 Land & buildings 2022: € 5,279 First fiscal year in the series	€ 3,880 Land & buildings 2023: € 3,880 ▼ 26% vs 2022 (€ 5,279) Unchanged	€ 2,482 Land & buildings 2024: € 2,482 ▼ 36% vs 2023 (€ 3,880) Unchanged	€ 4,954 Land & buildings 2025: € 4,954 ▲ 100% vs 2024 (€ 2,482) Unchanged	▲ 100%
Retained profit	€ 92,526 Retained profit 2022: € 92,526 First fiscal year in the series	€ 93,255 Retained profit 2023: € 93,255 ▲ 1% vs 2022 (€ 92,526) Favourable step	€ 93,400 Retained profit 2024: € 93,400 Unchanged (€ 93,255) Favourable step	€ 93,400 Retained profit 2025: € 93,400 Unchanged (€ 93,400) Unchanged
Dividend	€ 237,500 Dividend 2022: € 237,500 First fiscal year in the series	€ 238,000 Dividend 2023: € 238,000 Unchanged (€ 237,500) Unchanged	€ 270,000 Dividend 2024: € 270,000 ▲ 13% vs 2023 (€ 238,000) Unchanged	€ 250,307 Dividend 2025: € 250,307 ▼ 7% vs 2024 (€ 270,000) Unchanged	▼ 7%
Balance sheet total	€ 856,292 Balance sheet total 2022: € 856,292 First fiscal year in the series	€ 973,839 Balance sheet total 2023: € 973,839 ▲ 14% vs 2022 (€ 856,292) Unchanged	€ 1,186,693 Balance sheet total 2024: € 1,186,693 ▲ 22% vs 2023 (€ 973,839) Unchanged	€ 1,398,895 Balance sheet total 2025: € 1,398,895 ▲ 18% vs 2024 (€ 1,186,693) Unchanged	▲ 18%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	2.2 Employees (FTE) 2023: 2.2 ▼ 0.1 vs 2022 (2.3) Unchanged	2 Employees (FTE) 2024: 2 ▼ 0.2 vs 2023 (2.2) Unchanged	2.1 Employees (FTE) 2025: 2.1 ▲ 0.1 vs 2024 (2) Unchanged	▲ 0.1

Key figures of Apotheek Mertens, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Mertens?

What happened at Apotheek Mertens in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 21, 2026 New annual accounts for financial year 2025: profit of € 250,307 (▼ 7% vs 2024). Source: NBB ↗
2016 DESPO BV became a director. NBB
Jul 1, 1985 New establishment in Genk. KBO
May 14, 1985 Start of the company according to the CBE. KBO

In short

From € 237,771 profit in 2022 to € 250,307 profit in 2025.

Paid € 101,105 in corporate taxes since 2022.

Best year ever: 2024, with € 270,145 profit.

On average € 233,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DESPO 99.8%

The stake of DESPO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Mertens

Behind Apotheek Mertens is DESPO BV. The shares are held by DESPO (99.8%).

Directors

According to the 2025 annual accounts

DESPO BV

Director · represented by PIETER MERTENS

Also active at: OZOS - Optimale Zorg door Optimale Samenwerking, APOTHEEK BOXBERG

since 2016

Shareholders

DESPO

99.8%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zaveldriesstraat 14

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DE SCHRIJVER

€ 12,723 gross margin · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0427.269.459

VAT number

BE 0427.269.459

Registered office

Zaveldriesstraat 14, 3600 Genk

Names & denominations

Apotheek Mertens

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 May 1985

Peppol

Active · Active since 25 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Mertens

Financials

What happened to Apotheek Mertens?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions